摘要
目的:探讨儿童重症社区获得性肺炎合并肺不张的临床治疗。方法:儿童重症社区获得性肺炎合并肺不张的患儿80例,随机分为观察组和对照组,每组40例。2组均给予常规治疗,观察组在常规治疗基础上加用头孢曲松钠治疗,疗程4周,对比两组咳嗽缓解、退热、肺复张及疗效情况。结果:观察组的咳嗽缓解时间、退热时间及肺复张时间均明显低于对照组(P<0.01);观察组的有效率高于对照组(P<0.05)。结论:阿奇霉素联合头孢曲松钠治疗儿童重症社区获得性肺炎合并肺不张效果明显。
Objective:To explore the clinical treatment of severe community acquired pneumonia merger atelectasis in children. Methods:80 cases of children being diagnosed with severe community acquired pneumonia merger atelectasis were randomly divided into the observation group and the control group, 40 cases in each group. 2 groups were given conventional treatment, observation group was given Ceftriaxone sodium treatment on the basis of conventional therapy, each group&#39;s therapy was 4 weeks. Compared cough mitigation, pyretolysis and lung reexpansion situation of two groups. Results:The cough mitigation time, pyretolysis time and lung reexpansion situation time of observation group significantly lower than control group(P〈0.01);the effective power of observation group higher than control group(P〈0.05). Conclusions:Azithromycin combined with Ceftriaxone sodium in the treatment of severe community acquired pneumonia merger atelectasis in children had obviously effect.
出处
《中国医药导刊》
2013年第11期1768-1769,共2页
Chinese Journal of Medicinal Guide
关键词
重症社区获得性肺炎
肺不张
儿童
头孢曲松钠
Severe community acquired pneumonia
Atelectasis
Children
Ceftriaxone sodium